All tenants are medical-license holders, giving the portfolio 280E relief under the current order. [36][38]
| Quarter | Q1 FY26 |
|---|---|
| Call date | 2026-05-04 |
| Length | 35 minutes |
| EPS | $1.88 |
| EPS consensus | $1.77 |
| Revenue | $69.0M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY26 · Q4 FY25 · Q2 FY25
All IIPR earnings · Back to IIPR overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.